|
Market Closed -
Nasdaq
16:00:00 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 1.870 USD | -2.60% |
|
-4.59% | -47.77% |
| 08-18 | Top Premarket Decliners | MT |
| 05-19 | Natural Alternatives International, Inc. Provides Earnings Guidance for Fourth Quarter and Full Year 2026 | CI |
| Market Cap | 15M 13.08M 12.35M 11.21M 21.01M 1.44B 21.1M 148M 57.08M 732M 56.34M 55.09M 2.35B | P/E 2024 |
-4.89x | P/E 2025 | -1.44x |
|---|---|---|---|---|---|
| Enterprise Value | 61.7M 53.8M 50.8M 46.13M 86.44M 5.92B 86.8M 609M 235M 3.01B 232M 227M 9.69B | EV / Sales 2024 |
0.75x | EV / Sales 2025 | 0.52x |
| Free-Float |
50.96% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NAII | Delayed | |
CBOE
| NAII | Real-time | |
Deutsche Boerse AG
| NA2 | Delayed | |
Börse Stuttgart
| NA2 | Delayed | |
Boerse Muenchen
| NA2 | Real-time |
| 1 day | -2.60% | ||
| 1 week | -4.59% | ||
| Current month | -11.37% | ||
| 1 month | -8.33% | ||
| 3 months | -29.96% | ||
| 6 months | -28.63% | ||
| Current year | -47.77% |
| 1 week | 1.85 | 2.24 | |
| 1 month | 1.85 | 2.42 | |
| Current year | 1.85 | 4.96 | |
| 1 year | 1.85 | 4.96 | |
| 3 years | 1.85 | 7.37 | |
| 5 years | 1.85 | 15.5 | |
| 10 years | 0 | 19.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark LeDoux
CEO | Chief Executive Officer | 72 | 1985-12-31 |
Kenneth Wolf
DFI | Director of Finance/CFO | 65 | 2026-05-14 |
Nancy Steely
CTO | Chief Tech/Sci/R&D Officer | - | 2020-09-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark LeDoux
CHM | Chairman | 72 | 2000-12-31 |
Alan Dunn
BRD | Director/Board Member | 71 | 2003-12-31 |
Laura Matherly
BRD | Director/Board Member | 62 | 2019-12-05 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/6/26 | Free | Director | 8,000 | 0.1295% | ||
| 3/6/26 | Tax | Chief Financial Officer | 20,151 | 0.3262% | ||
| 3/6/26 | Free | Director | 8,000 | 0.1295% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.60% | -4.59% | -42.46% | -71.01% | 12.05M | ||
| +0.04% | +3.34% | +51.12% | +101.82% | 1,027B | ||
| -0.09% | +1.66% | +55.02% | +66.18% | 651B | ||
| -0.02% | +2.66% | +18.91% | +71.47% | 467B | ||
| -1.22% | +3.66% | +36.44% | +38.32% | 350B | ||
| -0.79% | +2.73% | +19.03% | +25.08% | 268B | ||
| +0.58% | +6.76% | +11.13% | +16.52% | 257B | ||
| +1.55% | +2.20% | +39.81% | +46.55% | 205B | ||
| +0.79% | +1.84% | -28.27% | -56.71% | 190B | ||
| -0.52% | +4.45% | +32.12% | +98.51% | 187B | ||
| Average | -0.08% | +2.20% | +19.29% | +33.67% | 360.21B | |
| Weighted average by Cap. | +0.23% | +3.01% | +35.17% | +61.81% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 114M 99.23M 93.7M 85.08M 159M 10.92B 160M 1.12B 433M 5.55B 427M 418M 17.86B | 130M 113M 107M 97.09M 182M 12.46B 183M 1.28B 494M 6.34B 488M 477M 20.38B |
| Net income | -7.22M -6.29M -5.94M -5.4M -10.11M -693M -10.15M -71.18M -27.47M -352M -27.11M -26.51M -1.13B | -13.58M -11.84M -11.18M -10.15M -19.02M -1.3B -19.1M -134M -51.67M -662M -50.99M -49.86M -2.13B |
| Net Debt | 48.31M 42.13M 39.78M 36.12M 67.68M 4.64B 67.96M 476M 184M 2.36B 181M 177M 7.58B | 46.7M 40.73M 38.46M 34.92M 65.43M 4.48B 65.7M 461M 178M 2.28B 175M 172M 7.33B |
Employees
293
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | US$1.870 | -2.60% | 8,582 |
| 26-09-17 | US$1.920 | -2.04% | 23,237 |
| 26-09-16 | US$1.960 | -0.51% | 14,741 |
| 26-09-15 | US$1.970 | +0.51% | 1,647 |
| 26-09-14 | US$1.960 | 0.00% | 35,846 |
- Stock Market
- Stocks
- NAII Stock
Select your edition
All financial news and data tailored to specific country editions

















